Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Biome Australia Ltd ( (AU:BIO) ) has issued an update.
Biome Australia Limited has reported a record quarterly sales revenue of $5.94 million for the first quarter of FY26, marking a 40% increase compared to the previous corresponding period and a 19% rise quarter-on-quarter. This achievement represents the company’s seventh consecutive quarter of positive EBITDA, amounting to $462,000, and highlights its strong financial performance with a cash balance increase to $2.94 million, indicating robust operational cash flow and financial stability.
The most recent analyst rating on (AU:BIO) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on Biome Australia Ltd stock, see the AU:BIO Stock Forecast page.
More about Biome Australia Ltd
Biome Australia Limited is a microbiome health company that focuses on developing products to support microbiome health. The company is listed on the Australian Securities Exchange under the ticker BIO.
Average Trading Volume: 325,455
Technical Sentiment Signal: Sell
Learn more about BIO stock on TipRanks’ Stock Analysis page.